| Healthcare and Medical Technology |
1 |
1 |
| COVID-19 |
0 |
0.69 |
| Clinical Research |
0 |
0.67 |
| Otolaryngology |
0 |
0.62 |
| Biologic Therapy |
0 |
0.99 |
| Fatigue |
0 |
0.27 |
| Nasopharyngitis |
0 |
0.27 |
| Thromboembolism |
0 |
0.23 |
| Graft Rejection |
0 |
0.19 |
| Thrombus |
0 |
0.19 |
| Upper Respiratory Tract Infection |
0 |
0.19 |
| Rheumatoid Arthritis |
0 |
0.16 |
| Anemia |
0 |
0.14 |
| Anticoagulation Therapy |
0 |
0.14 |
| Arthritis |
0 |
0.14 |
| Blood |
0 |
0.14 |
| Chronic Disease |
0 |
0.14 |
| Dizziness |
0 |
0.14 |
| Europe |
0 |
0.14 |
| Focal Segmental Glomerulosclerosis (FSGS) |
0 |
0.14 |
| Glucocorticoid |
0 |
0.14 |
| Intravenous |
0 |
0.14 |
| Ligament |
0 |
0.14 |
| NHS |
0 |
0.14 |
| Pain |
0 |
0.14 |
| Patient History |
0 |
0.14 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.14 |
| Quality of Life |
0 |
0.14 |
| Respiratory Tract |
0 |
0.14 |
| Thrombosis |
0 |
0.14 |
| Transplantation |
0 |
0.14 |
| Diarrhea |
0 |
0.12 |
| Herpes Zoster |
0 |
0.12 |
| Influenza |
0 |
0.12 |
| Neutropenia |
0 |
0.12 |
| Pain Management |
0 |
0.12 |
| Pneumonia |
0 |
0.12 |